Midgard Science

Zencore Biologics

Shanghai, China zencorebio.com From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

Zencore Biologics is an independent biologics CDMO headquartered in Lin-gang Special Area, Shanghai, China. It provides end-to-end services from cell line development and process development through GMP manufacturing, analytical support, and regulatory filing support for biopharmaceutical companies. It also has operations in the United States through its US Innovation Center in Germantown, Maryland.

Services

  • Research services

    Developability assessment, cell line development, early pharmaceutical research, and project feasibility evaluation.

  • Development services

    Process development and scale-up, analytical method development and validation, and pilot manufacturing for non-GMP/GMP work.

  • Manufacturing services

    Drug substance manufacturing, drug product filling, and global GMP supply.

    CDMO: development & manufacturing

  • Quality & regulatory

    Global CMC regulatory filings, quality management and compliance, and regulatory strategy support.

  • Biologics CDMO

    Integrated biologics CDMO services from developability assessment to commercial manufacturing.

    CDMO: development & manufacturing

  • ADC CDMO

    End-to-end ADC development and manufacturing from proof of concept to commercialization.

    CDMO: development & manufacturing

  • Cell culture media services

    Custom media development, pilot manufacturing, catalog media, and GMP commercial manufacturing.

    Protein production

  • Analytical services

    Biologics analysis and quality research from sequence to BLA, including release characterization and stability testing.

Turnaround
Delivery within one month
What to send
Project sample delivery

Capabilities

Assays and studies
  • ADCs
  • Antibodies
  • Process development
  • Bioreactors
  • Analytical development
  • Stability studies
11 more
  • Release characterization
  • Impurity identification
  • Similarity assessment
  • AUC
  • High-resolution mass spectrometry
  • Sequence analysis
  • Developability assessment
  • Method development and validation
  • Batch-to-batch consistency
  • Biosimilarity assessment
  • Cell line CQA testing
Scale and capacity
  • 25,000 L total capacity
  • 90,500 L planned capacity
  • 3×2,000 L single-use production lines
  • 3×5,000 L stainless-steel production lines
  • 4×200 L single-use bioreactors
  • 3×500 L single-use bioreactors
5 more
  • 1×500 L GMP pilot bioreactor
  • 2×200 L GMP pilot bioreactors
  • 200 tonnes/year annual media capacity
  • 10M+10M vials + prefilled syringes/year
  • 24,000 vials/hour

Instruments and platforms

  • AUC analytical ultracentrifugation
  • Q-TOF Waters high-resolution mass spectrometer
  • QE Thermo high-resolution mass spectrometer

Modalities and species

Modalities
  • Antibody
  • Bispecific
  • ADC
  • Peptide
Species and models
  • CHO-K1
  • CHO-DG44
  • CHO-S
  • CHOZN

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

  • ISO 13485Self-reported

    Scope: media manufacturing systems

Details

Type
CRDMO
Founded
2017
Office
289 Zhengjia Road
Sites
Germantown, Maryland, USA
Serves
Global

Public records

FDA drug establishment registration
3025687970 · ANALYSIS; MANUFACTURE source

Similar labs